Viroclinics Biosciences is a leader in the strongly growing and very dynamic market of diagnostic services companies. As a service organization we offer serological, virus-based and molecular analyses of any type of sample to assist our global customers with testing their antiviral drugs and vaccines. Our analyses encompass many types of viruses, including Influenza, RSV and Polio. Our rapidly growing company is now expanding its HBV Business Unit.
This expansion is part of our growth strategy and allows for hiring two new key leadership positions: a Director HBV Business Development and a Director HBV Services.
In this position you will be heading the HBV services group and report directly to the COO of the company.
In this position you will be heading the HBV business development effort of the company and report directly to the VP business development of the company.
OUR LATEST NEWS
The French ministry of research and innovation approves Viroclinics Biosciences as an intermediate vendor for The French Tax Credit Incentive (Crédit d’Impôt Recherche or CIR), a tax relief measure for companies focused on Research & Development activities.
Parcom Capital has acquired the successful clinical research organisation Viroclinics Biosciences. Viroclinics believes Parcom is the perfect partner to help it realise its growth ambitions.
Viroclinics Biosciences serves as a virology contract research organization in the bio pharmaceutical community with preclinical, clinical diagnostic, assay development and clinical trial logistics services. Especially with extensive experience in clinical and...